Back to 
Janus Henderson Group Ltd.
Janus Henderson Group Ltd.
EGRXShowing 0 of 20 quarters
Position history for Janus Henderson Group Ltd.'s holdings in EAGLE PHARMACEUTICALS INC
No. Janus Henderson exited its EGRX (Eagle Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 775,525 shares worth $4.1M. Janus Henderson already held EGRX in its Q2 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EGRX: STATE STREET CORP, BRANDES INVESTMENT PARTNERS, LP